Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEARNING TECHNOLOGIES GROUP PLC Director's Dealing 2019

Nov 26, 2019

7759_dirs_2019-11-26_76ccd1c2-1bb9-4958-ad4e-989be7903b08.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6756U

Learning Technologies Group PLC

26 November 2019

26 November 2019

Learning Technologies Group plc

(AIM: LTG)

Director dealing

Learning Technologies Group plc, the leading integrated learning and talent software and services provider, announces that Leslie-Ann Reed (Non-executive Director) has bought and sold 3,475,264 ordinary shares in the Company at an average price of 118.7 pence per Ordinary Share.

Following the transaction above, Leslie-Ann Reed's beneficial holding in the Company remains unchanged at 6,458,180 Ordinary Shares and this holding represents approximately 0.966 per cent of the Company's issued share capital.

Enquiries:

Learning Technologies Group plc

Jonathan Satchell, Chief Executive

Neil Elton, Chief Financial Officer
+44 (0)20 7402 1554
Numis Securities Limited

Stuart Skinner (Nominated Adviser)

Ben Stoop (Corporate Broker)
+44 (0)20 7260 1000
Goldman Sachs International (Joint Corporate Broker)

Bertie Whitehead / Adam Laikin
+44 (0)20 7774 1000
FTI Consulting (Public Relations Adviser)

Rob Mindell / Jamie Ricketts
+44 (0)20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGCBDBIXDBGCL